IP Library › Assignment 025727/0249
Patent Assignment
Reel/Frame 025727/0249

Assignment of Assignor's Interest

Recorded: 2011-02-01 Pages: 3
Assignor
LETAI, ANTHONY
Executed: 2006-05-16
Assignee
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215-5450
Covered Property (1)
BH3 Peptides and Method of Use Thereof
Patent: 9,856,303 →
Application: 12/966,821 →
Publication: US 2011/0154522
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 1, 2011
From: HOWARD HUGHES MEDICAL INSTITUTE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 025727/0358 →
Assignment of Assignor's Interest Feb 3, 2011
From: KORSMEYER, STANLEY J., MD
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 025737/0200 →
Corrective Assignment to Correct the Name of Assignee to Dana-Farber Cancer Institute, Inc. Previously Recorded on Reel 025727 Frame 0249. Assignor(S) Hereby Confirms the Conveyance from Anthony Letai to Dana-Farber Cancer Institute, Inc. Mar 27, 2014
From: LETAI, ANTHONY
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 032550/0742 →
Confirmatory License Dec 2, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040798/0195 →